Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

globenewswire.com

GlobeNewswire - Industry News on Pharmaceuticals

Get the latest updates from GlobeNewswire - Industry News on Pharmaceuticals directly as they happen.

Follow now 114 followers

Latest posts

Last updated about 1 hour ago

Tarsus to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

about 1 hour ago

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Tarsus Pharmaceuticals, Inc. (NASDAQ...

SciSparc Announces Updates Regarding Proposed Merger; Form F-4 Registration Statement Has Been Declared Effective by SEC

about 2 hours ago

TEL AVIV, Israel, July 30, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq...

Moleculin Receives Notice of Intent to Grant New European Patent for Annamycin

about 10 hours ago

– New patent enhances market position in Europe

NewAmsterdam Pharma Presents Positive Data from BROADWAY Trial Demonstrating Statistically Significant Reductions in Key Alzheimer’s Disease Biomarkers at AAIC 2025

about 10 hours ago

-- Pre-specified analysis shows obicetrapib significantly reduced absolute levels of plasma p-tau217...

Valitor Highlights Three-fold Increase with VLTR-559 in Sustained Potency and Durability over Aflibercept in Preclinical Ocular Wet AMD Models

about 10 hours ago

-Data showcased in session titled “Spotlight on Drug Delivery” at the Ophthalmology...

Avacta to Present New FAP Dox (AVA6000) Data at the European Society for Medical Oncology (ESMO) Congress

about 11 hours ago

LONDON and PHILADELPHIA, July 30, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM...

Madrigal Pharmaceuticals Enters into Exclusive Global License Agreement for Oral GLP-1 Receptor Agonist with CSPC Pharmaceutical Group Limited

about 14 hours ago

CONSHOHOCKEN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ...

Dr. Falk Pharma and Allianthera (Suzhou) Biopharmaceuticals Forge Strategic Partnership for Novel AhR Agonist Development

about 14 hours ago

Freiburg (Germany), Suzhou (China) and Boston (USA), July 30, 2025: